Drug profile · INN
vigabatrin
SABRIL
vigabatrin (SABRIL) is a gamma-amino-n-butyrate transaminase inhibitor. Associated with Sanofi-aventis Healthcare Pty Ltd. Route of administration: oral. Current US regulatory status: approved.
Drug details — vigabatrin
- US status
- approved
- Class
- Nervous system (N03)
- Route
- ORAL
- Patents
- 3
- Programs
- 3
- Data quality
- 0.89
Quick answer
vigabatrin (SABRIL) is a gamma-amino-n-butyrate transaminase inhibitor. Associated with Sanofi-aventis Healthcare Pty Ltd. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Gamma-amino-N-butyrate transaminase inhibitor
Primary target: 4-aminobutyrate aminotransferase, mitochondrial
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| EMA | approved | — |
| TGA | approved | — |
Pipeline programs
Related & competitor drugs
Related patents
-
US 12285397
Use of (s)-3-amino-4-(difluoromethylenyl) cyclopent-1-ene-1-carboxylic acid and related compounds, (1S,3S)-3-amino-4-(difluoromethylidene) cyclopentane-1-carboxylic acid and vigabatrin in the treatment of developmental disorders
granted -
US 11660277
Use of (S)-3-amino-4-(difluoromethylenyl) cyclopent-1-ene-1-carboxylic acid and related compounds, (1S,3S)-3-amino-4-(difluoromethylidene) cyclopentane-1-carboxylic acid and vigabatrin in the treatment of developmental disorders
granted -
US 10813899
Use of (s)-3-amino-4-(difluoromethylenyl) cyclopent-1-ene-l-carboxylic acid and related compounds, (1s,3S)-3-amino-4-(difluoromethylidene) cyclopentane-1-carboxylic acid and vigabatrin in the treatment of developmental disorders
granted
Frequently asked questions
What is vigabatrin?
vigabatrin (SABRIL) is a gamma-amino-n-butyrate transaminase inhibitor. Associated with Sanofi-aventis Healthcare Pty Ltd. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for vigabatrin?
SABRIL is a marketed brand name for vigabatrin. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of vigabatrin?
vigabatrin has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.